Comparative microbial genomics, microbial infections leading to cancers and SNV’s in leading to disorders and genetic conditions and strategies to adopt for the therapeutics of the pathogenic targets.

Document Type

News Article


Currently my area of research deals with the efforts to understand the various antibiotic strategies and the possible therapeutics to deal with the specific drug targets involved. Also working on few metabolic disorders involving the estrogens and the associated type of the cancers and their management through the nutrigenomics approach. I am also interested in addressing a genetic variations involved in causing pediatric cancers by specifically looking into the pathogenic mutations and polymorphisms and screening the compounds with potential interactions with the mutated protein/ genes.

  1. https://manipal.pure.elsevier.com/en/publications/review-on-antimicrobial-resistant-genes-mechanisms-and-next-gener
  2. https://manipal.pure.elsevier.com/en/publications/comparative-genomics-based-putative-drug-targets-identification-h
  3. https://manipal.pure.elsevier.com/en/publications/a-comprehensive-review-on-antihyperglycemic-phytochemicals-from-w
  4. https://www.tandfonline.com/doi/abs/10.1080/07391102.2021.1930160?journalCode=tbsd20
  5. https://pubmed.ncbi.nlm.nih.gov/23904736/

Publication Date

Spring 10-30-2022